Cardinal Health, Inc. (NYSE:CAH) will release its fourth quarter earnings report before the opening bell on Tuesday, Aug. 11.
Analysts expect the Dublin, Ohio-based company to report quarterly earnings of $2.42 per share, up from $2.08 per share in the year-ago period. The consensus estimate for Cardinal Health’s quarterly revenue is $65.11 billion. It reported $60.16 billion last year, according to Benzinga Pro.
On July 20, Cardinal Health announced plans to acquire the diabetes health business of Adapthealth and, in its entirety, Strive Medical for $360 million in cash.
Shares of Cardinal Health rose 0.3% to close at $237.18 on Monday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Mizuho analyst Steven Valiquette maintained an Outperform rating and increased the price target from $235 to $240 on July 23, 2026. This analyst has an accuracy rate of 56%.
- UBS analyst Kevin Caliendo maintained a Buy rating and raised the price target from $260 to $274 on July 20, 2026. This analyst has an accuracy rate of 71%.
- TD Cowen analyst Charles Rhyee maintained a Buy rating and raised the price target from $255 to $275 on July 9, 2026. This analyst has an accuracy rate of 71%.
- B of A Securities analyst Allen Lutz maintained the stock with a Buy rating and raised the price target from $240 to $260 on July 2, 2026. This analyst has an accuracy rate of 55%.
- JP Morgan analyst Lisa Gill maintained the stock with a Neutral rating and cut the price target from $243 to $215 on May 4, 2026. This analyst has an accuracy rate of 56%
Considering buying CAH stock? Here’s what analysts think:
Photo via Shutterstock